Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea
0
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Purpose: Benign prostatic hyperplasia (BPH) is associated with lower urinary tract symptoms and negatively affects the quality of life. We aimed to investigate the treatment pattern of BPH in South Korea. Methods: Information on treatment modalities and diagnoses of BPH was obtained from the Health Insurance Review and Assessment Service-Aged Patient Sample. Data on BPH patients aged ≥60 years from 2012 to 2016 were obtained. We surveyed the treatment pattern of BPH, including the types of drugs used and surgeries performed, according to the type of institution. Results: In this study, 18,260–24,657 BPH patients treated between 2012 and 2016 were included. The number of patients showed an increasing pattern, and drug therapy was the major treatment method used for BPH (98.77%). Moreover, the pattern of increased pharmacotherapy use for BPH was reinforced by the increasing number of patients. Prescription of α-blockers only was dominant in this cohort (45.7%). Transurethral resection of the prostate (TURP) was the most commonly used surgical treatment for BPH (53.6%), but it showed a decreasing pattern over time. In contrast, holmium laser enucleation of the prostate (HoLEP) showed an increase from 19.4% to 39.7%. Conclusions: The most common treatment for BPH was drug therapy, predominantly only α-blocker therapy. The surgical treatment trend has changed from TURP to HoLEP.
Abstract
Purpose: Benign prostatic hyperplasia (BPH) is associated with lower urinary tract symptoms and negatively affects the quality of life. We aimed to investigate the treatment pattern of BPH in South Korea. Methods: Information on treatment modalities and diagnoses of BPH was obtained from the Health Insurance Review and Assessment Service-Aged Patient Sample. Data on BPH patients aged ≥60 years from 2012 to 2016 were obtained. We surveyed the treatment pattern of BPH, including the types of drugs used and surgeries performed, according to the type of institution. Results: In this study, 18,260–24,657 BPH patients treated between 2012 and 2016 were included. The number of patients showed an increasing pattern, and drug therapy was the major treatment method used for BPH (98.77%). Moreover, the pattern of increased pharmacotherapy use for BPH was reinforced by the increasing number of patients. Prescription of α-blockers only was dominant in this cohort (45.7%). Transurethral resection of the prostate (TURP) was the most commonly used surgical treatment for BPH (53.6%), but it showed a decreasing pattern over time. In contrast, holmium laser enucleation of the prostate (HoLEP) showed an increase from 19.4% to 39.7%. Conclusions: The most common treatment for BPH was drug therapy, predominantly only α-blocker therapy. The surgical treatment trend has changed from TURP to HoLEP.
참고문헌 (28)
- Irwin DE, "Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries:results of the EPIC study", Eur Urol, 50, pp.1306~1314 (2006)
- 서준교, "Comprehensive Review of Effective Application of Questionnaires for Clinical Research on Lower Urinary Tract Symptoms With Translation and Cultural Adaptation to the Korean Language", International Neurourology Journal, 24(4), pp.313~323 (2020), 대한배뇨장애요실금학회[DOI]
- Gratzke C, "EAU guidelines on the assessment of nonneurogenic male lower urinary tract symptoms including benign prostatic obstruction", Eur Urol, 67, pp.1099~1109 (2015)
- 전병조, "Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System Data", International Neurourology Journal, 23(1), pp.22~29 (2019), 대한배뇨장애요실금학회[DOI]
- Na R, "A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia(BPH)and lower urinary tract symptoms(LUTS)", Prostate, 77, pp.1213~1220 (2017)
- Wilson JD, "The pathogenesis of benign prostatic hyperplasia", Am J Med, 68, pp.745~756 (1980)
- 정원식, "Men With Severe Lower Urinary Tract Symptoms Are at Increased Risk of Depression", International Neurourology Journal, 19(4), pp.286~292 (2015), 대한배뇨장애요실금학회
- 조정기, "Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey", International Neurourology Journal, 21(2), pp.143~151 (2017), 대한배뇨장애요실금학회
- 김규식, "Do Lifestyle Factors Affect Lower Urinary Tract Symptoms? Results from the Korean Community Health Survey", International Neurourology Journal, 23(2), pp.125~135 (2019), 대한배뇨장애요실금학회[DOI]
- Souverein PC, "Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery", Eur Urol, 43, pp.528~534 (2003)
- Malaeb BS, "National trends in surgical therapy for benign prostatic hyperplasia in the United States(2000-2008)", Urology, 79, pp.1111~1116 (2012)
- Izard J, "Impact of medical therapy on transurethral resection of the prostate : two decades of change", BJU Int, 108, pp.89~93 (2011)
- Vela-Navarrete R, "The impact of medical therapy on surgery for benign prostatic hyperplasia : a study comparing changes in a decade(1992-2002)", BJU Int, 96, pp.1045~1048 (2005)
- Cindolo L, "Actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia : temporal trends of prescription and hospitalization rates over 5 years in a large population of Italian men", Int Urol Nephrol, 46, pp.695~701 (2014)
- Oelke M, "EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction", Eur Urol, 64, pp.118~140 (2013)
- 최세영, "Impact of Changing Trends in Medical Therapy on Surgery for Benign Prostatic Hyperplasia Over Two Decades", Investigative and Clinical Urology, 53(1), pp.23~28 (2012), 대한비뇨의학회
- Elkoushy MA, "Changing patients’ profile presenting for surgical management of benign prostatic hyperplasia over the past 16 years : a single-centre perspective", Can Urol Assoc J, 9, pp.372~378 (2015)
- Mayer EK, "Examining the ‘gold standard’ : a comparative critical analysis of three consecutive decades of monopolar transurethral resection of the prostate(TURP)outcomes", BJU Int, 110, pp.1595~1601 (2012)
- Borth CS, "Impact of medical therapy on transurethral resection of the prostate : a decade of change", Urology, 57, pp.1082~1085 (2001)[DOI]
- He LY, "The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention", Asian J Androl, 18, pp.134~139 (2016)
- Reich O, "Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10, 654 patients", J Urol, 180, pp.246~249 (2008)
- Djavan B, "Urodynamic assessment of patients with acute urinary retention : is treatment failure after prostatectomy predictable", J Urol, 158, pp.1829~1833 (1997)
- Negro CL, "Chronic urinary retention in men: how we define it, and how does it affect treatment outcome", BJU Int, 110, pp.1590~1594 (2012)
- Presicce F, "Can long-term LUTS", BPH pharmacological treatment alter the outcomes of surgical intervention, 2017, pp.18, 72~
- Van Koeveringe GA, "Factors impacting bladder underactivity and clinical implications", Minerva Urol Nefrol, 67, pp.139~148 (2015)
- Blatt AH, "Transurethral prostate resection in patients with hypocontractile detrusor-what is the predictive value of ultrastructural detrusor changes", J Urol, 188, pp.2294~2299 (2012)
- Oelke M, "Can we identify men who will have complications from benign prostatic obstruction(BPO)? ICI-RS 2011", Neurourol Urodyn, 31, pp.322~326 (2012)
- Tubaro A, "The evolving picture of lower urinary tract symptom management", Eur Urol, 67, pp.271~272 (2015)